3-氨基-5-氰基三氟甲苯 | 49674-28-4

• 物质功能分类: 有机原料 - 有机氟化合物 - 氟甲苯系列
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-氨基-5-氰基三氟甲苯
• 英文名称: 3-amino-5-(trifluoromethyl)benzonitrile
• 英文别名: 3-cyano-5-trifluoromethylaniline
• CAS: 49674-28-4
• 化学式: C₈H₅F₃N₂
• mdl: MFCD09955455
• 分子量: 186.136
• InChiKey: UMUDGXVSXIXLCF-UHFFFAOYSA-N

物化性质

• 沸点：
  279.3±40.0 °C(Predicted)
• 密度：
  1.37±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  49.8
• 氢给体数：
  1
• 氢受体数：
  5

安全信息

• 海关编码：
  2926909090
• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H302
• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-Amino-5-(trifluoromethyl)benzonitrile
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Amino-5-(trifluoromethyl)benzonitrile
CAS number: 49674-28-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H5F3N2
Molecular weight: 186.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

• 上游原料

  中文名称	英文名称	CAS号	化学式	分子量
  3-氰基-5-硝基三氟甲苯	3-nitro-5-(trifluoromethyl)benzonitrile	20566-80-7	C8H3F3N2O2	216.119
  5-三氟甲基-3-溴苯腈	3-bromo-5-(trifluoromethyl)benzonitrile	691877-03-9	C8H3BrF3N	250.018

• 下游产品

  中文名称	英文名称	CAS号	化学式	分子量
  3-(氨基甲基)-5-(三氟甲基)苯胺	5-(aminomethyl)-3-(trifluoromethyl)aniline	1233324-80-5	C8H9F3N2	190.168
  5-三氟甲基-3-溴苯腈	3-bromo-5-(trifluoromethyl)benzonitrile	691877-03-9	C8H3BrF3N	250.018
  ——	1-[3-amino-5-(trifluoromethyl)phenyl]ethanone	880882-04-2	C9H8F3NO	203.164
  ——	phenyl (3-cyano-5-(trifluoromethyl)phenyl)carbamate	1229454-69-6	C15H9F3N2O2	306.244

反应信息

• 作为反应物：
  描述：

  3-氨基-5-氰基三氟甲苯 在 盐酸 、 potassium iodide 、 sodium nitrite 作用下， 以 水 为溶剂， 反应 0.5h， 以72.8%的产率得到3-Iodo-5-(trifluoromethyl)benzonitrile
  参考文献：
  名称：

  [EN] GAMMA-AMINOAMIDE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
  [FR] MODULATEURS GAMMA-AMINOAMIDES DE L'ACTIVITE DE RECEPTEUR DE CHIMIOKINE

  摘要：

  本发明涉及式(I)的化合物，其中R1、R2、R3、R4、R5、R6、R7、R8、R11、R12、W、X和n在此处定义，这些化合物可用作趋化因子受体活性的调节剂。特别是，这些化合物可用作趋化因子受体CCR-2的调节剂。

  公开号：

  WO2004041279A1
• 作为产物：
  描述：

  3-氰基-5-硝基三氟甲苯 在 氯化铵 、 锌 作用下， 以 乙醇 、 水 为溶剂， 反应 14.0h， 以81%的产率得到3-氨基-5-氰基三氟甲苯
  参考文献：
  名称：

  [EN] INHIBITORS OF NECROPTOSIS
  [FR] INHIBITEURS DE NÉCROPTOSE

  摘要：

  本发明涉及式(I)的新杂环化合物，这些化合物能抑制坏死性凋亡，并涉及它们的使用方法。这些化合物可能用于治疗与坏死性凋亡调节异常相关的病症。

  公开号：

  WO2016127213A1

文献信息

• [EN] PYRROLIDINONE CARBOXAMIDE DERIVATIVES AS CHEMERIN-R ( CHEMR23 ) MODULATORS<br/>[FR] DÉRIVÉS DE PYRROLIDINONE CARBOXAMIDE UTILISÉS EN TANT QUE MODULATEURS DU RÉCEPTEUR DE LA CHÉMÉRINE (CHEMR23)
  申请人：CHEMOCENTRYX INC

  公开号：WO2011035332A1

  公开（公告）日：2011-03-24

  Pyrrolidinone carboxamide compounds of formula (I) are provided that are useful for inhibiting the binding of ligands to the ChemR23 receptor.

  提供的化合物是吡咯烷酮甲酰胺化合物，其分子式为(I)，可用于抑制配体与ChemR23受体的结合。
• [EN] IMIDAZOPYRIDAZINECARBONITRILES USEFUL AS KINASE INHIBITORS<br/>[FR] IMIDAZOPYRIDAZINECARBONITRILES POUVANT ÊTRE EMPLOYÉS EN TANT QU'INHIBITEURS DE KINASE
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2010042699A1

  公开（公告）日：2010-04-15

  The invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof. The Formula (I) imidazopyridazines inhibit protein kinase activity thereby making them useful as anticancer agents.

  该发明提供了式（I）的化合物及其药用可接受的盐。式（I）的咪唑吡啶嗪抑制蛋白激酶活性，因此使它们作为抗癌药物有用。
• [EN] TETRAZOLE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS<br/>[FR] COMPOSÉS DE TÉTRAZOLE COMME BLOQUEURS DES CANAUX CALCIQUES
  申请人：CONVERGENCE PHARMACEUTICALS

  公开号：WO2012004604A1

  公开（公告）日：2012-01-12

  The present invention relates to novel tetrazole compounds; to processes for their preparation; to pharmaceutical compositions containing the compounds; and to the use of the compounds in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial. Formula (I) wherein A is: (II) or (III)

  本发明涉及新型四唑化合物；它们的制备方法；含有这些化合物的药物组合物；以及利用这些化合物在治疗中治疗阻断Cav2.2钙通道有益的疾病。其中A为：(II)或(III)。
• [EN] IMIDAZOPYRIDAZINE COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES<br/>[FR] COMPOSÉS IMIDAZOPYRIDAZINE UTILES EN TANT QUE MODULATEURS DE RÉPONSES À IL-12, IL-23 ET/OU IFNΑ
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2017087590A1

  公开（公告）日：2017-05-26

  Compounds of formula I or a stereoisomer or pharmaceutically-acceptable salt thereof, are useful in the modulation of IL-12, IL-23 and/or IFNα, by acting on Tyk-2 to cause signal transduction inhibition.

  式I或其立体异构体或药用可接受盐的化合物，通过作用于Tyk-2以引起信号传导抑制，对调节IL-12、IL-23和/或IFNα具有用处。
• [EN] NEW HETEROCYCLIC AMIDES<br/>[FR] NOUVEAUX AMIDES HETEROCYCLIQUES
  申请人：ASTRAZENECA AB

  公开号：WO2006033620A1

  公开（公告）日：2006-03-30

  The present invention relates to new compounds (I) or salts, solvates or solvated salts thereof, processes for their preparation and to new intermediates used in the preparation thereof, pharmaceutical compositions containing said compounds and to the use of said compounds in therapy.

  本发明涉及新化合物（I）或其盐、溶剂合物或溶剂化盐，以及用于其制备的新中间体，含有所述化合物的药物组合物以及所述化合物在治疗中的用途。